Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg?
- PMID: 30391902
- DOI: 10.1016/j.jneuroim.2018.10.006
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg?
Abstract
Recent studies suggest a role of the autoimmune system dysregulation in Frontotemporal dementia (FTD). In the present study, we performed a broad immunological screening in a large sample of sporadic FTD patients. We reported a significant increase of antinuclear autoantibodies (ANA) positivity in 100 FTD patients as compared to 100 healthy controls (HC) (60% vs. 13%, p < .001). In FTD, ANA-positive and ANA-negative patients did not differ for any clinical feature. These data extend and further confirm autoimmune dysregulation in FTD. However, it still remains to be clarified whether these antibodies have a potential pathogenic role or represent simply an epiphenomenon.
Copyright © 2018 Elsevier B.V. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources